Improving alcohol treatment in HIV care through practice facilitation
Official title: A Hybrid Type III Implementation Trial Testing Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care
Run by Johns Hopkins University · NCT05241990 · Data updated 2026-11-12
This study is testing whether helping HIV clinics better use alcohol reduction programs can improve care for people living with HIV who struggle with drinking.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Johns Hopkins University Academic / other |
| Locations | 3 sites (San Diego, California and 2 other locations) |
| Status | Recruiting |
| Started | February 15, 2023 |
| Main results expected | June 15, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | June 26, 2026 |
| Trial ID | NCT05241990 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with HIV who exhibit unhealthy alcohol use as indicated by specific screening scores.
✕Probably not a fit
Patients who do not exhibit unhealthy alcohol use or are under 18 years old may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of practice facilitation as a strategy to enhance the adoption and implementation of alcohol reduction interventions in HIV care settings. It utilizes established frameworks to assess how well these interventions can be integrated into clinical practice across three HIV clinics in Boston, San Diego, and Chapel Hill. The goal is to improve patient outcomes by addressing unhealthy alcohol use, which is known to hinder HIV treatment adherence and viral suppression.
Why it matters
Potential benefit: If successful, this approach could significantly improve the management of alcohol use in patients with HIV, leading to better health outcomes and adherence to treatment.
How similar studies have gone: Other studies have shown promise in using implementation strategies like practice facilitation to improve treatment adoption in healthcare settings, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Clinic Staff * Age \> 18 years old * Confirmed to be clinic staff (clinical or administrative roles). * English speaking * Cognitively able to complete required survey or interview activities. Exclusion Criteria Clinic Staff * Unable to speak English Inclusion Criteria, Patients * Confirmed to be a person with HIV (PWH) receiving HIV care and participating in CNICS at one of the three clinic sites * Scoring AUDIT-C ≥3 for women or ≥4 for men, transgender women or men indicating unhealthy alcohol use. * Age ≥ 18 years old. * English speaking. * Cognitively able to participate in stepped care for unhealthy alcohol use. Exclusion Criteria, Patients * Scoring AUDIT-C \<3 for women or \<4 for men or \<4 for transgender women or men * Age \< 18 years old * Participants cognitively unable to participate in the stepped care for unhealthy alcohol use.
Where it's running
-
University of California, San Diego
San Diego, California, United States Recruiting -
Fenway Community Health
Boston, Massachusetts, United States Not yet recruiting -
University of North Carolina
Chapel Hill, North Carolina, United States Not yet recruiting
Study contacts
- Principal investigator: Geetanjali Chander, MD — Johns Hopkins University
- Study coordinator: JoAnna Mathena
- Email: jmathen5@jhmi.edu
- Phone: 410-955-9534
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
New ways to diagnose lymphoma and multicentric Castleman disease in people living with HIV
This study tests a quick, point-of-care nucleic acid test to help diagnose lymphoma and multicentric Castleman disease in people living with HIV in sub-Saharan Africa.
-
Bridge to Belonging: A Peer‑Led Program to Reduce Loneliness and Depression in older gay and bisexual men with HIV
This program tests a peer-delivered, manualized approach to help men aged 50+ with HIV connect to LGBTQ+-affirming elder services to see if it reduces loneliness and depressive symptoms.
-
HIV vaccine test in healthy adults using CH505 nanoparticles and mRNA boosters
This early-stage study will test the safety and immune responses of CH505 vaccine regimens in healthy adults to see if they can trigger HIV-specific immune protection.
-
Stigma-reducing program to help women who use drugs stay in HIV care
This test checks whether a stigma-reduction program helps women living with HIV who use drugs stay engaged in HIV care in Ukraine.
-
Platelets and HIV Reservoirs: A look at how platelets might harbor HIV in people living with HIV
This observational study tests whether HIV can be found inside platelets in adults with suppressed HIV on therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.